Browse diseases

…Background In January 2024, all people with multiple sclerosis (pwMS) treated with natalizumab (NTZ) at Oslo University Hospit…

… incidental finding of MRI evidence of demyelination suggesting multiple sclerosis in someone with no corresponding clinical signs or symptoms. RI…

…rrelates with reduced relapse rates and increased disability in multiple sclerosis (MS). Biological age may better capture ageing’s impact on MS a…

… Higher vitamin D has consistently been associated with a lower multiple sclerosis (MS) risk, but some controversy remains about whether this is d…

…aired in pwMS receiving anti-CD20 or S1PR therapies, but severe COVID-19 was rare. These findings support continued vaccination programm…

…Objectives Systemic lupus erythematosus (SLE) is characterized with diverse clinical manifestations. Ge…

…Introduction People with multiple sclerosis (MS) engage in less physical activity and experience higher rat…

…conditions without cognitive impairment (myocardial infarction, prostate cancer, female breast cancer), and employed event–study difference-in-…

…ependent of relapse activity (PIRA) is a relevant unmet need in multiple sclerosis (MS), being only modestly affected by disease-modifying treatme…

… autologous haematopoietic stem cell transplantation (AHSCT) in multiple sclerosis (MS). AHSCT has potent and durable efficacy for patients with a…

…5% female). Resolution of at least one T2-lesion differentiated MOGAD from MS (sensitivity, (95% CI 77% to 100%), specificity, (95% C…

…Background Multiple sclerosis (MS) is the most common neuroimmunological disease in young adu…